RxDoctor Payments Data

Lisa Colvin

Psychiatric/Mental Health · Dothan, ALNPI 1639937840

Payments from drug & device makers

$1,567in general payments, 2019–2025

Across 78 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$586
  • Neurocrine Biosciences, Inc.$214
  • Alkermes, Inc.$205
  • Vanda Pharmaceuticals Inc.$109
  • Otsuka America Pharmaceutical, Inc.$106
  • AbbVie$76
  • plus $271 from 6 others

What the payments were for

  • Food & beverage$1,567100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,567 in reported general payments places this provider in the 60th percentile of 378 psychiatric/mental health providers in Alabama.

See all psychiatric/mental health providers in Alabama

Medicare billing

Part B allowed, 2024
$5,124
Medicare patients
61
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate40$138,107
Abilify MaintenaAripiprazole13$39,704
Paliperidone ErPaliperidone26$6,078
Fluphenazine Hcl17$3,555
Ziprasidone Hcl20$1,969
Benztropine Mesylate99$1,730
Fluphenazine Decanoate16$1,705
Clozapine12$1,375
Trazodone Hcl72$1,104
Quetiapine Fumarate47$970
Divalproex Sodium ErDivalproex Sodium11$884
Olanzapine38$871
Doxepin Hcl27$759
Aripiprazole15$731
Risperidone55$719

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$586$138,10740 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$106$39,70413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 378 psychiatric/mental health providers in Alabama.

Other psychiatric/mental health in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →